Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Sampath Parthasarathy

Sampath Parthasarathy

University of Central Florida, USA

Title: Significance of lipid peroxidation-cationic protein interactions in atherosclerosis in attenuation of inflammatory response

Biography

Biography: Sampath Parthasarathy

Abstract

Apolipoprotein (Apo A1) and apolipoprotein E (Apo E) mimetic peptides have attracted attention due to their ability to reduce atherosclerosis and exhibit antioxidant, anti-inflammatory, and hypolipidemic properties. Based on the nature of the peptide, we predicted that these effects could be attributed to their positively charged amino acid residues and hydrophobicity. Accordingly, we designed and tested whether three distinct and unrelated cationic peptides would inhibit the oxidation of lipoproteins, neutralize the charge of negatively charged modified lipoproteins, and inhibit the latter’s uptake by macrophages. As bacterial lipopolysaccharide (LPS) is also a highly negatively charged molecule, we also tested the peptides to affect LPS induced macrophage inflammatory response. 

5F-mimetic peptide of apoA1, LL27 derived from the anti-microbial peptide CAMP, and a human glycodelin derived peptide was commercially synthesized. The number of positively charged amino acid residues (K+R) and negatively charged residues (D+E) were 4/4, 7/4, 6/2 respectively. Their abilities to reduce lipid peroxides (LOOH), inhibit the oxidation lipoproteins (LDL & HDL), interact with modified lipoproteins, and to inhibit macrophage uptake of modified LDL and inflammation were analyzed.  Their abilities to inhibit LPS and Ox-LDL induced inflammatory responses also were determined.

Cationic peptides decomposed 13-HPODE and inhibited the oxidation of LDL in a lysine dependent manner. Incubation of Ox-LDL and Ac-LDL with the peptides resulted in charge neutralization. Pre-incubation of the peptides with modified lipoproteins reduced the uptake of the latter by macrophages and foam cell formation as detected by Oil-Red O staining. Increased inflammatory gene expressions were observed in the presence of LPS/Ox-LDL. However, peptides inhibited the Ox-LDL-induced inflammatory gene expressions but showed a dual effect on LPS induced inflammatory response. In contrast, native LDL, which has several positively charged domain formed complexes with Ox-LDL and increased macrophage cholesterol accumulation.

Based on these studies, we suggest that cationic peptides may be a valuable tool for controlling Ox-LDL mediated inflammation and atherosclerotic progression. However, the Ox-LDL, in the presence of native LDL might be more atherogenic and suggest a potential competition between soluble peptides and intact lipoproteins.